Literature DB >> 23672743

Advances in management of thyroid cancer.

Judy Jin1, Roy Phitayakorn, Scott M Wilhelm, Christopher R McHenry.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23672743     DOI: 10.1067/j.cpsurg.2013.02.001

Source DB:  PubMed          Journal:  Curr Probl Surg        ISSN: 0011-3840            Impact factor:   1.909


× No keyword cloud information.
  6 in total

Review 1.  Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literature.

Authors:  Wei-dong Zhang; Da-ren Liu; Cheng-cheng Feng; Chuan-biao Zhou; Chen-ni Zhan; Ri-sheng Que; Li Chen
Journal:  J Zhejiang Univ Sci B       Date:  2014-12       Impact factor: 3.066

2.  Evaluating the Time Interval for Presenting the Signs of Hypocalcaemia after Thyroidectomy.

Authors:  Mostafa Hosseini; Hamidreza Alizadeh Otaghvar; Adnan Tizmaghz; Ghazaal Shabestanipour; Parichehr Atef Vahid
Journal:  J Clin Diagn Res       Date:  2016-03-01

3.  Endoscopic thyroidectomy along with bilateral central neck dissection (ETBC) increases the risk of transient hypoparathyroidism for patients with thyroid carcinoma.

Authors:  Dapeng Xiang; Liangqi Xie; Zhiyu Li; Ping Wang; Mao Ye; Mingzhu Zhu
Journal:  Endocrine       Date:  2016-02-17       Impact factor: 3.633

4.  Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion.

Authors:  Wei Gao; Jiakai Han
Journal:  Oncol Res       Date:  2016-11-17       Impact factor: 5.574

5.  Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer.

Authors:  Yan Zhang; Gang Liu; Shihe Wu; Futing Jiang; Jiangping Xie; Yuhong Wang
Journal:  Onco Targets Ther       Date:  2016-03-29       Impact factor: 4.147

6.  Impact of the Body Mass Index on Hemorrhage After Surgery for Thyroid Cancer.

Authors:  Peng Li; Ruihua Luo; Lanwei Guo; Wenlu Li; Jinxing Qi
Journal:  Cancer Manag Res       Date:  2020-01-23       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.